Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines

Circulation

Volumn 98, Issue 9, 1998, Pages 851-855

  Frolkis, Joseph P ^a,c,d   Zyzanski, Stephen J ^c   Schwartz, Jonathan M ^b   Suhan, Pamela S ^a  

^a Mt Sinai Medical Center Cleveland   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medicine ^*  (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Compliance; Lipoproteins; Practice guidelines; Risk factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING;

EID: 0032168473     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.9.851     Document Type: Article

References (15)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994;344:1383-1389.
2. Shepard J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Mac Farlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333: 1301-1307.
3. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335: 1001-1009.
4. The Expert Panel. Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
5. Summary of the second report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
6. Cohen MV, Byrne M, Levine B, Gutowski T, Adelson R. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. Circulation. 1991;83: 1294-1304.
7. Giles WH, Anda RF, Jones DH, Serdula MK, Merritt RK, DeStefano F. Recent trends in the identification and treatment of high blood cholesterol by physicians. JAMA. 1993;269:1133-1138.
8. Miller M, Konkel K, Fitzpatrick D, Burgan R, Vogel RA. Divergent reporting of coronary risk factors before coronary artery bypass surgery. Am J Cardiol. 1995;75:736-737.
9. Nieto FJ, Alonso J, Chambless LE, Zhing M, Ceraso M, Romm FJ, Cooper L, Folsom AR, Szklo M. Population awareness and control of hypertension and hypercholesterolemia. Arch Intern Med. 1995;155: 677-684.
10. Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease. JAMA. 1997;277:1281-1286.
11. Peterson ED, Shaw LK, DeLong ER, Pryor DB, Califf RM, Mark DB. Racial variation in the use of coronary revascularization procedures. N Engl J Med. 1997;336:480-486.
12. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329:103-109.
13. Gotto AM. Cholesterol management on theory and practice. Circulation. 1997;96:4424-4430.
14. Barrett-Connor E. Lowering cholesterol in patients with coronary heart disease: are we ready yet? Circulation. 1997;96:4124-4125.
15. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events. Am J Cardiol. 1995;76: 570-573.